Crescendo Bioscience (San Francisco, CA) a commercial-stage molecular diagnostics company focused on quantitative biomarker tests for rheumatoid, closed a $31M Series C financing. Participants include Aeris Capital, Mohr Davidow Ventures and Kleiner Perkins Caufield & Byers.